Plasma Amino Acid Levels After Protein Ingestion or Amino Acid Injection During Dialysis

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

July 31, 2020

Conditions
End Stage Renal Disease on Dialysis (Diagnosis)
Interventions
DRUG

Aminoven 10%

"After randomization to the visit Day 60, two months after patients inclusion (Visit Day 0) and one month after clinical examination (Visit Day 30), patients will be assigned to a group:~* group A: RENORAL® product~* group B: AMINOVEN® 10% product~* group C: control group (without intradialytic supplementation)~Patients will consume the products and will be followed for 3 months, one visit per month (Day 90, Day 120, Day 150). Protocol visits are included in the patient's course of care."

DIETARY_SUPPLEMENT

RENORAL

"After randomization to the visit Day 60, two months after patients inclusion (Visit Day 0) and one month after clinical examination (Visit Day 30), patients will be assigned to a group:~* group A: RENORAL® product~* group B: AMINOVEN® 10% product~* group C: control group (without intradialytic supplementation)~Patients will consume the products and will be followed for 3 months, one visit per month ( V3, V4, V5). Protocol visits are included in the patient's course of care."

Trial Locations (1)

59240

RECRUITING

Hopital Center, Dunkirk

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioFortis

OTHER

lead

Indigo Therapeutics

INDUSTRY